Table 3.
Characteristics of patients with ypT+N+
| No adjuvant CTx (n=76) | Adjuvant CTx (n=38) | p-value | |
|---|---|---|---|
| Age (yr) | 62 (42–84) | 58 (45–72) | 0.018 |
| Male sex | 72 (94.7) | 36 (94.7) | > 0.99 |
| FEV 1 (L) | 3.0±0.6 | 3.0±0.6 | 0.867 |
| DLCo (%) | 85.1±17.1 | 84.5±15.1 | 0.868 |
| Postoperative complications | 56 (73.7) | 27 (71.1) | 0.825 |
| ASA | |||
| 1 | 13 (17.1) | 15 (39.5) | 0.027 |
| 2 | 60 (78.9) | 21 (55.3) | |
| 3 | 3 (3.9) | 2 (5.3) | |
| cStage (AJCC 7th) | |||
| II | 9 (11.8) | 6 (15.8) | 0.664 |
| III | 66 (86.9) | 32 (84.2) | |
| IV | 1 (1.3) | 0 | |
| ypStage (AJCC 7th) | |||
| II | 21 (27.6) | 11 (28.9) | 0.865 |
| III | 54 (71.1) | 26 (68.4) | |
| IV | 1 (1.3) | 1 (2.6) | |
Values are presented as median (range), number (%), or mean±SD. AJCC, American Joint Committee on Cancer; ASA, American Society of Anesthesiology; CTx, chemotherapy; DLCo, diffusing capacity of the lungs for carbon monoxide; FEV1, forced expiratory volume in 1 second; SD, standard deviation.